LIC Q2 Results: Profit Jumps 20%, Premiums Rise 16%. One Category Did The Heavy Lifting
Life Insurance Corporation moved higher in a quarterly results development with September 30 in focus.
· NDTV Profit
LIC's net premium income jumped 16.2% to Rs 1.47 lakh crore for the quarter ended on September 30…
Key facts
- Dates in focus
- September 30
The analysis
Life Insurance Corporation reported Rs 1.47 lakh crore, with movement of 20%, 16% and 16.2% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +0.0% on the day at ₹408.00, and has returned +3.8% over three months. It sits 12% below its 52-week high. The insurance sector has moved -10.9% over the same period, so Life Insurance Corporation is running 14.7 points ahead of its peers.
For Life Insurance Corporation, the question is how much of this is already reflected in the price and how much re-rates the insurance peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Life Insurance Corporation (LIC) (LICI), in Insurance.
- Over three months: Life Insurance Corporation (LIC) +3.8% against Insurance -10.9% (14.7 points ahead).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Life Insurance Corporation (LIC)LICI · Insurance | ₹408.00 | 0.0% | +5.0% | +3.8% | -11.7% | 1.7× | — |
Insurance
1M -0.1% · 3M -10.9%
Life Insurance Corporation (LIC)
Prices as of 5 Nov 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
LIC Q2FY27 results: Net profit increases 20% to ₹12,076 crore
IDBI Bank stake sale: Why employees are protesting against Fairfax deal and demanding privatisation rollback
SBI vs SBI Life vs SBI Cards: Which SBI Group stock emerged as the Q2 results 2026 winner? Check analyst targets
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 crore
Airtel Q2 preview: Analysts see double-digit revenue growth; ARPU in focus